Northwire Canada EditionSaturday, July 18, 2026
Sign inSubscribe
Northwire
⌕
AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0% AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0%

Healthcare

Page 117
  1. Oct 20, 2025 · 16:04 · ZYUS

    ZYUS Life Sciences Corporation Announces Closing of Additional Secured Loan

    ZYUS Life Sciences Corporation Announces Closing of Additional Secured Loan

    01
  2. Oct 20, 2025 · 12:03 · SONA

    Sona Nanotech sees 80% response in cancer study

    Sona Nanotech sees 80% response in cancer study

    02
  3. Oct 20, 2025 · 09:00 · ZCT

    Zero Candida Achieves Design Freeze and Begins Prototype Production of ZC-001 Therapeutic Device

    Zero Candida Achieves Design Freeze and Begins Prototype Production of ZC-001 Therapeutic Device

    03
  4. Oct 20, 2025 · 09:00 · VHI

    VitalHub Announces Q3 2025 Conference Call Date

    VitalHub Announces Q3 2025 Conference Call Date

    04
  5. Oct 20, 2025 · 08:30 · QNTM

    Quantum BioPharma Ltd. Announces Expiration of All Warrants Held by Hedge Funds and Re-Iterates October 27, 2025, Record Date for the Distribution of a Special Dividend

    Quantum BioPharma Ltd. Announces Expiration of All Warrants Held by Hedge Funds and Re-Iterates October 27, 2025, Record Date for the Distribution of a Special Dividend

    05
  6. Oct 20, 2025 · 07:30 · DHT

    DRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the U.S. Sales of Veligrotug and VRDN-003 for the Treatment of Thyroid Eye Disease (TED)

    DRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the U.S. Sales of Veligrotug and VRDN-003 for the Treatment of Thyroid Eye Disease (TED)

    06
  7. Oct 20, 2025 · 07:30 · BCT

    BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

    BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

    07
  8. Oct 20, 2025 · 07:01 · PREV

    PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.

    PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.

    08
  9. Oct 20, 2025 · 06:01 · SONA

    Sona Nanotech Reports 80% Response Rate in First-In-Human THT Cancer Therapy Study

    Sona Nanotech Reports 80% Response Rate in First-In-Human THT Cancer Therapy Study

    09
  10. Oct 17, 2025 · 22:33 · UDOC

    Unidoc Health amends LIFE offering

    Unidoc Health amends LIFE offering

    10
  11. Oct 17, 2025 · 18:56 · CRDL

    Cardiol closes $11-million (U.S.) placement

    Cardiol closes $11-million (U.S.) placement

    11
  12. Oct 17, 2025 · 18:50 · UDOC

    UniDoc Announces Amended LIFE Offering

    UniDoc Announces Amended LIFE Offering

    12
  13. Oct 17, 2025 · 16:35 · CRDL

    Cardiol Therapeutics Secures US$11 Million Financing and Extends Cash Runway into Q3 2027

    Cardiol Therapeutics Secures US$11 Million Financing and Extends Cash Runway into Q3 2027

    13
  14. Oct 17, 2025 · 16:05 · SONA

    Sona Nanotech To Host Investor Webinar To Discuss Clinical Study

    Sona Nanotech To Host Investor Webinar To Discuss Clinical Study

    14
← Newer Older →